T0	Limitation 30805 30812	Whether
T1	Limitation 30691 30693	It
T2	SampleSize 30720 30751	appropriate patient populations
T3	OutcomeMeasures 30756 30772	outcome measures
T4	StudyDuration 30777 30803	selected for future trials
T5	Intervention 30805 30913	Whether quilizumab could have a clinically meaningful effect in another subgroup of allergic asthma patients
T6	Intervention 30917 30979	whether a treatment period beyond 36Â weeks would show efficacy
